CAS 1801765-04-7

TNO155

CAS : 1801765-04-7

TNO155 inhibits SHP2 enzyme with an IC50 of 0.011 μM, potentially aiding cancer treatment.

Formule : C₁₈H₂₄ClN₇OS

Degré de pureté : 98.03% - >99.99%

Couleur et forme : Solid

Masse moléculaire : 421.95

Ref: TM-T13176

(3S,4S)-8-(6-Amino-5-((2-amino-3-chloropyridin-4-yl)sulfanyl)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro( 4.5)decan-4-amine

CAS : 1801765-04-7

Formule : C₁₈H₂₄ClN₇OS

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 421.9475

Ref: IN-DA01KFZR

TNO155

CAS : 1801765-04-7

TNO155

Degré de pureté : ≥98%

Masse moléculaire : 421.95g/mol

Ref: 54-BUP08948

TNO155

CAS : 1801765-04-7

TNO155 is an innovative therapeutic agent, commonly classified as a small-molecule inhibitor, which is derived from rational drug design based on precision oncology principles. Its mode of action involves selective inhibition of a specific protein tyrosine phosphatase, which plays a critical role in cellular signaling pathways that are often dysregulated in cancer. This inhibition effectively disrupts aberrant signaling, thereby suppressing tumor cell proliferation and inducing apoptosis in malignant cells.

Formule : C₁₈H₂₄ClN₇OS

Degré de pureté : Min. 95%

Masse moléculaire : 421.9 g/mol

Ref: 3D-BT179499